Differentiation of endothelial progenitor cells into endothelial cells byheparin-modified supramolecular pluronic nanogels encapsulating bFGF and complexed with VEGF165 genes

Biomaterials

Volumn 35, Issue 16, 2014, Pages 4716-4728

  Yang, Han Na ^a   Choi, Jong Hoon ^b   Park, Ji Sun ^a   Jeon, Su Yeon ^a   Park, Ki Dong ^b   Park, Keun Hong ^a  

^a CHA University   (South Korea)

^b Ajou University   (South Korea)

Author keywords

Differentiation; EPCs; Genes; Growth factor; Nanogel

Indexed keywords

CELL CULTURE; CONTROLLED DRUG DELIVERY; DIFFERENTIATION (CALCULUS); ENDOTHELIAL CELLS; GENE TRANSFER; GENES; POLYSACCHARIDES; PROTEINS; STEM CELLS; SUPRAMOLECULAR CHEMISTRY; TARGETED DRUG DELIVERY;

BASIC FIBROBLAST GROWTH FACTOR; ENDOTHELIAL PROGENITOR CELLS; ENDOTHELIAL PROGENITOR CELLS (EPCS); EPCS; GROWTH FACTOR; NANOGELS; NEO-VASCULARIZATION; STEM CELL DIFFERENTIATION;

NANOSTRUCTURED MATERIALS;

FIBROBLAST GROWTH FACTOR; GROWTH FACTOR; HEPARIN; PLASMID DNA; POLOXAMER; VASCULOTROPIN 165;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; ENDOTHELIAL PROGENITOR CELL; ENDOTHELIUM CELL; FEMALE; GENE TARGETING; HUMAN; HUMAN TISSUE; HYDROPHILICITY; LIMB ISCHEMIA; MOUSE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PRIORITY JOURNAL; SURFACE PROPERTY;

ANIMALIA;

DIFFERENTIATION; EPCS; GENES; GROWTH FACTOR; NANOGEL;

ANIMALS; CELL DIFFERENTIATION; CELLS, CULTURED; DNA; DRUG CARRIERS; ENDOTHELIAL CELLS; FEMALE; FIBROBLAST GROWTH FACTOR 2; HEPARIN; HUMANS; MICE, INBRED BALB C; NEOVASCULARIZATION, PHYSIOLOGIC; POLOXAMER; POLYETHYLENE GLYCOLS; POLYETHYLENEIMINE; STEM CELLS; TRANSFECTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84896544895     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2014.02.038     Document Type: Article

References (32)

1. Uchiyama T. Human T cell leukemia virus type I (HTLV-I) and human diseases. Annu Rev Immunol 1997, 15:15-37.
2. Nickel W. The mystery of nonclassical protein secretion. A current view on cargo proteins and potential export routes. Eur J Biochem 2003, 270(10):2109-2119.
3. Yamaguchi T., Kanayasu-Toyoda T., Uchida E. Angiogenic cell therapy for severe ischemic diseases. Biol Pharm Bull 2013, 36(2):176-181.
4. Kim J., Jeon Y.J., Kim H.E., Shin J.M., Chung H.M., Chae J.I. Comparative proteomic analysis of endothelial cells progenitor cells derived from cord blood- and peripheral blood for cell therapy. Biomaterials 2013, 34(6):1669-1685.
5. Park S.J., Moon S.H., Lee H.J., Lim J.J., Kim J.M., Seo J., et al. Acomparison of human cord blood- and embryonic stem cell-derived endothelial progenitor cells in the treatment of chronic wounds. Biomaterials 2013, 34(4):995-1003.
6. Stroncek J.D., Grant B.S., Brown M.A., Povsic T.J., Truskey G.A., Reichert W.M. Comparison of endothelial cell phenotypic markers of late-outgrowth endothelial progenitor cells isolated from patients with coronary artery disease and healthy volunteers. Tissue Eng Part A 2009, 15(11):3473-3486.
7. Han J.K., Lee H.S., Yang H.M., Hur J., Jun S.I., Kim J.Y., et al. Peroxisome proliferator-activated receptor-delta agonist enhances vasculogenesis by regulating endothelial progenitor cells through genomic and nongenomic activations of the phosphatidylinositol 3-kinase/Akt pathway. Circulation 2008, 118(10):1021-1033.
8. Caporali A., Pani E., Horrevoets A.J., Kraenkel N., Oikawa A., Sala-Newby G.B., et al. Neurotrophin p75 receptor (p75NTR) promotes endothelial cell apoptosis and inhibits angiogenesis: implications for diabetes-induced impaired neovascularization in ischemic limb muscles. Circ Res 2008, 103(2):e15-e26.
9. Ergün S., Tilki D., Hohn H.P., Gehling U., Kilic N. Potential implications of vascular wall resident endothelial progenitor cells. Thromb Haemost 2007, 98(5):930-939.
10. Atluri P., Trubelja A., Fairman A.S., Hsiao P., Macarthur J.W., Cohen J.E., et al. Normalization of postinfarct biomechanics using a novel tissue-engineered angiogenic construct. Circulation 2013, 128(26 Suppl.1):S95-S104.
11. Conese M., Carbone A., Castellani S., Di Gioia S. Paracrine effects and heterogeneity of marrow-derived stem/progenitor cells: relevance for the treatment of respiratory diseases. Cells Tissues Organs 2013, 197(6):445-473.
12. Tu D.D., Chung Y.G., Gil E.S., Seth A., Franck D., Cristofaro V., et al. Bladder tissue regeneration using acellular bi-layer silk scaffolds in a large animal model of augmentation cystoplasty. Biomaterials 2013, 34(34):8681-8689.
13. Hendrickx B., Vranckx J.J., Luttun A. Cell-based vascularization strategies for skin tissue engineering. Tissue Eng Part B Rev 2011, 17(1):13-24.
14. Liu Y., Jiang X., Yu M.K., Dong J., Zhang X., Tsang L.L., et al. Switching from bone marrow-derived neurons to epithelial cells through dedifferentiation and translineage redifferentiation. Cell Biol Int 2010, 34(11):1075-1083.
15. Lim L.S., Hong F.H., Kunarso G., Stanton L.W. The pluripotency regulator Zic3 is a direct activator of the Nanog promoter in ESCs. Stem Cells 2010, 28(11):1961-1969.
16. Park K.H., Kim H., Moon S., Na K. Bone morphogenic protein-2 (BMP-2) loaded nanoparticles mixed with human mesenchymal stem cell in fibrin hydrogel for bone tissue engineering. JBiosci Bioeng 2009, 108(6):530-537.
17. Wu H.F., Cen J.S., Zhong Q., Chen L., Wang J., Deng D.Y., et al. The promotion of functional recovery and nerve regeneration after spinal cord injury by lentiviral vectors encoding Lingo-1 shRNA delivered by Pluronic F-127. Biomaterials 2013, 34(6):1686-1700.
18. Hawkins A.M., Bottom C.E., Liang Z., Puleo D.A., Hilt J.Z. Magnetic nanocomposite sol-gel systems for remote controlled drug release. Adv Healthc Mater 2012, 1(1):96-100.
19. Kanzler I., Tuchscheerer N., Steffens G., Simsekyilmaz S., Konschalla S., Kroh A., et al. Differential roles of angiogenic chemokines in endothelial progenitor cell-induced angiogenesis. Basic Res Cardiol 2013, 108(1):310.
20. Ferrara N. Vascular endothelial growth factor. Eur J Cancer 1996, 32A:2413-2422.
21. Petrova T.V., Makinen T., Alitalo K. Signaling via vascular endothelial growth factor receptors. Exp Cell Res 1999, 253:117-130.
22. Plouet J., Moro F., Bertagnolli S., Coldeboeuf N., Mazarguil H., Clamens S., et al. Extracellular cleavage of the vascular endothelial growth factor 189-amino acid form by urokinase is required for its mitogenic effect. JBiol Chem 1997, 272:13390-13396.
23. Neufeld G., Cohen T., Gengrinovitch S., Poltorak Z. Vascular endothelial growth factor (VEGF) and its receptors. FASEB J 1999, 13:9-22.
24. Cho S.K., Kwon Y.J. Simultaneous gene transduction and silencing using stimuli-responsive viral/nonviral chimeric nanoparticles. Biomaterials 2012, 33(11):3316-3323.
25. Ahmed M., Narain R. The effect of molecular weight, compositions and lectin type on the properties of hyperbranched glycopolymers as non-viral gene delivery systems. Biomaterials 2012, 33(15):3990-4001.
26. Masuda T., Akita H., Niikura K., Nishio T., Ukawa M., Enoto K., et al. Envelope-type lipid nanoparticles incorporating a short PEG-lipid conjugate for improved control of intracellular trafficking and transgene transcription. Biomaterials 2009, 30(27):4806-4814.
27. Zou D., Zhang Z., He J., Zhang K., Ye D., Han W., et al. Blood vessel formation in the tissue-engineered bone with the constitutively active form of HIF-1α mediated BMSCs. Biomaterials 2012, 33(7):2097-2108.
28. Rumsey S.C., Obunike J.C., Arad Y., Deckelbaum R.J., Goldberg I.J. Lipoprotein lipase-mediated uptake and degradation of low density lipoproteins by fibroblasts and macrophages. JClin Invest 1992, 90(4):1504-1512.
29. Shen H., Hu X., Yang F., Bei J., Wang S. Cell affinity for bFGF immobilized heparin-containing poly(lactide-co-glycolide) scaffolds. Biomaterials 2011, 32(13):3404-3412.
30. Kim J.H., Park J.S., Yang H.N., Woo D.G., Jeon S.Y., Do H.J., et al. The use of biodegradable PLGA nanoparticles to mediate SOX9 gene delivery in human mesenchymal stem cells (hMSCs) and induce chondrogenesis. Biomaterials 2011, 32(1):268-278.
31. Yang H.N., Park J.S., Woo D.G., Jeon S.Y., Park K.H. Transfection of VEGF(165) genes into endothelial progenitor cells and invivo imaging using quantum dots in an ischemia hind limb model. Biomaterials 2012, 33(33):8670-8684.
32. Park J.S., Yang H.N., Woo D.G., Jeon S.Y., Park K.H. Poly(N-isopropylacrylamide-co-acrylic acid) nanogels for tracing and delivering genes to human mesenchymal stem cells. Biomaterials 2013, 34(34):8819-8834.